...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: Thoughts on ZCC
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I agree that he needs to say less of promises that he might not keep but that doesn't interfere with reporting what has happened. If it is causes out of his control, he can tell us what happened. Right now, it mostly keeps pointing at their abyssmal financial situation and the markets aren't liking that. His exuberance of last spring and none of it coming to fruitition or even starting has just made it look like he has no clue how this industry operates even though he is paid as if he is a knowledgeable CEO. A CEO that appears to not know what he is doing doesn't sell well to the market. If he does know what he is doing, he needs to step up and show us either by getting it done or explaining what went wrong. Hiding does not sell!

10 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply